rs10127395

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181303.2(NLGN3):​c.727+3316T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.53 in 108,664 control chromosomes in the GnomAD database, including 12,677 homozygotes. There are 16,159 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 12677 hom., 16159 hem., cov: 21)

Consequence

NLGN3
NM_181303.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.313

Publications

3 publications found
Variant links:
Genes affected
NLGN3 (HGNC:14289): (neuroligin 3) This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. Mutations in this gene may be associated with autism and Asperger syndrome. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Oct 2009]
NLGN3 Gene-Disease associations (from GenCC):
  • autism, susceptibility to, X-linked 1
    Inheritance: XL, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: MODERATE Submitted by: ClinGen, Illumina

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_181303.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.828 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181303.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLGN3
NM_181303.2
MANE Select
c.727+3316T>G
intron
N/ANP_851820.1X5DNV3
NLGN3
NM_018977.4
c.667+3316T>G
intron
N/ANP_061850.2Q9NZ94-2
NLGN3
NM_001166660.2
c.607+3316T>G
intron
N/ANP_001160132.1X5D7L6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLGN3
ENST00000358741.4
TSL:5 MANE Select
c.727+3316T>G
intron
N/AENSP00000351591.4Q9NZ94-1
NLGN3
ENST00000374051.7
TSL:1
c.667+3316T>G
intron
N/AENSP00000363163.3Q9NZ94-2
NLGN3
ENST00000395855.7
TSL:1
c.607+3316T>G
intron
N/AENSP00000379196.3E7EVK0

Frequencies

GnomAD3 genomes
AF:
0.530
AC:
57515
AN:
108613
Hom.:
12681
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.836
Gnomad AMI
AF:
0.392
Gnomad AMR
AF:
0.573
Gnomad ASJ
AF:
0.586
Gnomad EAS
AF:
0.181
Gnomad SAS
AF:
0.251
Gnomad FIN
AF:
0.391
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.394
Gnomad OTH
AF:
0.545
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.530
AC:
57569
AN:
108664
Hom.:
12677
Cov.:
21
AF XY:
0.520
AC XY:
16159
AN XY:
31088
show subpopulations
African (AFR)
AF:
0.836
AC:
25088
AN:
30001
American (AMR)
AF:
0.573
AC:
5861
AN:
10224
Ashkenazi Jewish (ASJ)
AF:
0.586
AC:
1523
AN:
2597
East Asian (EAS)
AF:
0.181
AC:
608
AN:
3360
South Asian (SAS)
AF:
0.253
AC:
640
AN:
2533
European-Finnish (FIN)
AF:
0.391
AC:
2166
AN:
5542
Middle Eastern (MID)
AF:
0.625
AC:
130
AN:
208
European-Non Finnish (NFE)
AF:
0.393
AC:
20482
AN:
52051
Other (OTH)
AF:
0.546
AC:
812
AN:
1488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
851
1702
2552
3403
4254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.466
Hom.:
4372
Bravo
AF:
0.555

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.15
DANN
Benign
0.81
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10127395;
hg19: chrX-70378529;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.